Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.21.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accounts receivable, net of allowance (in Dollars) $ 260 $ 39
Preferred stock par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, authorized 300,000,000 300,000,000
Common stock, issued 72,486,962 55,508,314
Common stock, outstanding 72,486,962 55,508,314
Series A Preferred Stock    
Preferred stock, shares authorized 1,684,375 1,684,375
Preferred stock, issued
Preferred stock, outstanding
Series B Preferred Stock    
Preferred stock, shares authorized 1,580,790 1,580,790
Preferred stock, issued 926,942 926,942
Preferred stock, outstanding 926,942 926,942
Liquidation preference (in Dollars) $ 19,663
Non-Voting Common Stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, authorized 3,553,000 3,553,000
Common stock, issued 896 896
Common stock, outstanding 896 896